Malta Bank Will Not Back the Country’s Medical Cannabis Plans

8th November 2019
By Emily Ledger

Malta has been making strives in the past year in an attempt to enter, and profit from, the growing global medical Cannabis sector. However, the Bank of Valletta has announced that it will not back the plans, stumping government officials and investors. 

The Bank of Valletta has claimed that it will not have any involvement with Malta’s proposed medical Cannabis sector. A spokesperson for the bank quoted a lack of knowledge and unwillingness to take the risk, as reasons for the discrepancy.

CEO of the Bank of Valletta Mario Mallia said in a television interview:

“We do not have the necessary skills to understand this business. If you do not understand the business, how can you take risks?”

He continued: “If the government is promoting it, it does not mean that the banks have the risk appetite to accommodate the industry.”

The government, and particularly Prime Minister Joseph Muscat, have been pushing plans to expand the country’s medical Cannabis industry, through exports. Muscat has previously claimed that the expansion could create 900 new jobs on the island, and export €1 billion worth of products over the next three years.

However, this latest development involving the bank of Valletta will complicate these plans. The new industry may have to seek assistance from other EU bodies, leaving the Maltese bank behind.

The bank’s decision has been met with disbelief from investors. One entrepreneur, Reggie Fava, has previously criticised the Bank of Valletta for taking a lack of interest in the proposals. “When I see something new, that is something I can cultivate and grow – it is new and innovative. So why can’t we work together?”

Over 400 Cannabis prescriptions have been issued in Malta since the island legalised medical Cannabis in March 2018. However, critics have claimed that this number is still low when considering the number of doctors on the island.

 

Related Stories

Would you like to know the results of our polls? Please complete the data request form by clicking here.

About the Author

Emily Ledger
Prior to joining the team at Canex, Emily studied Journalism at Sheffield Hallam University for three years. During her studies, she specialised in magazine and feature writing and went on to contribute to both the content and design departments at a local magazine. Emily is now the Head of Content at Canex where she has been both curating and contributing articles and content since the launch of the website.

Enjoying this article?

Join the thousands of subscribers who stay ahead of the game.

Advertise on Canex

Reach thousands of customers, as well as industry leaders and manufacturers
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email
Share on reddit
Reddit
Share on whatsapp
WhatsApp

Subscribe to our newsletter

All the latest CBD news & updates, direct to your inbox
By submitting this form, you are giving Canex permission to contact you directly via email or telephone. You can opt out at any stage, and your contact data will never be shared with any 3rd party without your explicit consent. Our Privacy Policy.

Keeping subscribers up-to-date with news & insight within the CBD industry. From regulation and legislation reforms, industry updates and guides through the ongoing studies of the substance; to product news, reviews and guides.

© 2020 | Canex Group Ltd | All Rights Are Reserved